Booster Shots in Children Ages 5–11 Increase Omicron Antibodies, Pfizer Says

Video Credit: Wibbitz Top Stories
Published on April 14, 2022 - Duration: 01:30s

Booster Shots in Children Ages 5–11 Increase Omicron Antibodies, Pfizer Says

Booster Shots in Children Ages 5–11 , Increase Omicron Antibodies, Pfizer Says.

NBC News reports a booster shot of the Pfizer-BioNTech coronavirus vaccine increases antibody protection in children ages 5-11, the company said on April 14.

NBC News reports a booster shot of the Pfizer-BioNTech coronavirus vaccine increases antibody protection in children ages 5-11, the company said on April 14.

Given half a year after the initial series of two doses, a booster shot of the Pfizer-BioNTech vaccine increased antibody levels sixfold.

In Pfizer's clinical trial, 140 children ages 5 through 11 received a booster shot.

According to NBC News, data has not yet been made available to independent researchers for review.

In the era of Omicron, booster doses of COVID vaccines have been hit and miss.

In adults, a booster dose of Pfizer's vaccine wanes dramatically after four months.

Health experts say the same trends are likely to occur in children.

For adults, Pfizer's vaccine is 30 micrograms per dose.

For children, vaccines are 10 micrograms per dose.

Earlier this year, New York Department of Health researchers found Pfizer's vaccine to offer minimal protection against infection in children.

But according to NBC, the CDC later said two doses in children offered ample protection against severe infections.

But according to NBC, the CDC later said two doses in children offered ample protection against severe infections


You are here


💡 newsR Knowledge: Other News Mentions


BioNTech

German biotechnology company


Related videos from verified sources

3 Out of 4 Kids in the US Have Had COVID, CDC Estimates 01:31
Video credit: Wibbitz Top Stories - Published on April 27, 2022 

Moderna Working on Vaccine Booster That Targets the Omicron Variant 01:30
Video credit: Wibbitz Top Stories - Published on April 19, 2022 

What's Next for COVID-19 Vaccines? 01:30
Video credit: Wibbitz Top Stories - Published on April 5, 2022 

You might like